wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33378902-5E49AFB6-CE41-4145-8664-715D590D243E
Q33378902-5E49AFB6-CE41-4145-8664-715D590D243E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33378902-5E49AFB6-CE41-4145-8664-715D590D243E
A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors
P2860
Q33378902-5E49AFB6-CE41-4145-8664-715D590D243E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33378902-5E49AFB6-CE41-4145-8664-715D590D243E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2751c58350b61f4c90a4013bed5017a53da42f1a
P2860
Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma.